Aesica Launches New Brand Identity
News Oct 13, 2015
Following its recent acquisition by Consort Medical, Aesica Pharmaceuticals has announced the launch of its new brand identity. This reflects the new alignment and consolidation of the full Consort Medical group.
The combination of Aesica and Bespak enables Consort Medical to provide customers with a single source for drug and device development, formulation, manufacturing and packaging. The group’s unrivalled global offering comprises advanced delivery technologies, formulation development and manufacturing solutions for drugs.
Aesica provides API and finished dose formulation development and manufacturing services. Bespak is a global market leader in the development and manufacture of drug delivery devices.
The new logo and branding will be adopted across all Consort Medical businesses, creating a consistent identity for all group companies. The official launch to the market is planned for 13th October, to coincide with CPhI 2015.
The core vision focuses on delivery of early stage development to full scale manufacturing services that help customers to streamline complex supply chains and, in doing so, accelerates the route of drugs to market, reducing cost and complexity for the group’s partners.
The new logo has been inspired by the ‘joining together’ of the companies – with the three-cornered vertex designed to represent a dynamic company that is at the leading edge of innovation.
Many life-saving medicines, including insulin, antibodies and vaccines, are derived from living cells. These “biologics” can be difficult to obtain and store on the battlefield or in remote areas. That’s why scientists are trying to develop portable systems that can quickly manufacture small batches of protein therapeutics on demand.READ MORE
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019
Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress
Oct 24 - Oct 26, 2019